MolMed reports top line results of NGR-hTNF in the phase III trial in malignant pleural mesothelioma

May 24, 2016 | Author: social_molmed | Category: N/A


Description

MolMed S.p.A. (MLM.MI) today announced the results of the double-blinded, placebo-controlled Phase III trial of NGR-hTNF...

Comments

SUPPORT DOCURI